Dean Schorno
Directeur Financier/CFO chez RIGEL PHARMACEUTICALS, INC.
Fortune : 443 180 $ au 30/04/2024
Postes actifs de Dean Schorno
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 29/05/2018 | - |
Historique de carrière de Dean Schorno
Anciens postes connus de Dean Schorno
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Directeur des opérations | 17/08/2015 | 01/05/2018 |
| Directeur Financier/CFO | 17/08/2015 | 01/05/2018 | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur Financier/CFO | 24/06/2014 | 10/08/2015 |
| GENOMIC HEALTH, INC. | Directeur Financier/CFO | 10/01/2011 | 01/07/2014 |
| Investor Relations Contact | 01/07/2003 | 01/07/2014 | |
| Public Communications Contact | 01/07/2003 | 01/07/2014 | |
| Corporate Officer/Principal | 01/02/2010 | 10/01/2011 |
Formation de Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director of Finance/CFO | 4 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Bourse
- Insiders
- Dean Schorno
- Expérience